En françaisIn English
Member Login Ouvrir une session

Clinical Guidelines & Position Statements

Publication Date

Canadian Position Statement on Opioid Therapy 2017
CRA Guidelines Handbook 2017
Canadian Position Statement on Biosimilars and Innovator Molecules 2017
Canadian Position Statement on Management of Juvenile Idiopathic Arthritis 2016
Canadian Position Statement on Ethical Prescribing 2015
Canadian Position Statement on Medical Marijuana  2015
Canadian Review on Cannabinoid Treatments for Rheumatic Diseases   2015
Canadian Recommendations for the Management of Spondyloarthropathy  2014
Cardiovascular Risk with Diclofenac:  Response to Health Canada  2014
Chronic pain, Diclofenac and Cardiovascular Risk:  Management Algorithm 2014
Canadian Confidence with Cannabinoids in Rheumatic Diseases:  A Survey of Rheumatologists 2014
Canadian Recommendations for Management of RA  2012
Canadian Fibromyalgia Guidelines 2012

Lignes directrices et énoncés de position

Date de publication

Énoncé de position canadien sur les opioïdes chez les patients arthritiques 2017
CRA Guidelines Handbook* 2017
Énoncé de position canadien sur les biosimilaires et les molécules novatrices 2017
Canadian Position Statement on Management of Juvenile Idiopathic Arthritis* 2016
Énoncé de la position du Canada sur la prescription éthique 2015
Canadian Position Statement on Medical Marijuana * 2015
Canadian Review on Cannabinoid Treatments for Rheumatic Diseases * 2015
Canadian Recommendations for the Management of Spondyloarthropathy* 2014
Risque cardiovasculaire et diclofénac: Réponse à Santé  2014
Chronic pain, Diclofenac and Cardiovascular Risk:  Management Algorithm* 2014
Canadian Confidence with Cannabinoids in Rheumatic Diseases:  A Survey of Rheumatologists * 2014
Recommandations canadiennes pour la prise en charge de la PR  2012
Lignes directrices canadiennes sur la fibromyalgie 2012
*disponible en anglais seulement